These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 854478)

  • 1. The effect of a low-protein diet on some pharmacokinetic parameters of hexobarbital in the rat.
    Czyzewska-Szafran H; Nowak K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1977; 29(1):1-6. PubMed ID: 854478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of low protein diet on sleeping time and on the metabolism of hexobarbital in rats.
    Czyzewska-Szafran H; Lastowska K; Obojska K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1975; 27(6):625-30. PubMed ID: 1208235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors affecting the metabolism and response to hexobarbital.
    Furner RL; Gram TE; Stitzel RE
    Pharmacology; 1969; 2(3):181-9. PubMed ID: 5346144
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Circadian fluctuations of pharmacokinetic parameters after oral administration of hexobarbital (author's transl)].
    Altmayer P; Groterath E; Lücker PW; Mayer D; von Mayersbach H; Rindt W; Wetzelsberger K
    Arzneimittelforschung; 1979; 29(9):1422-8. PubMed ID: 583253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic fate of hexobarbital in the rat.
    Holcomb RR; Gerber N; Bush MT
    J Pharmacol Exp Ther; 1974 Jan; 188(1):15-26. PubMed ID: 4809266
    [No Abstract]   [Full Text] [Related]  

  • 8. [The relationship between the inhibition of protein synthesis and the induction of microsomal enzymes by barbital (author's transl)].
    Kröner H
    Z Klin Chem Klin Biochem; 1973 Jan; 11(1):20-3. PubMed ID: 4804137
    [No Abstract]   [Full Text] [Related]  

  • 9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethanol on rates of elimination and metabolism of zoxazolamine, hexobarbital and warfarin sodium in the rat.
    Mallov S; Baesl TJ
    Biochem Pharmacol; 1972 Jun; 21(12):1667-78. PubMed ID: 4649128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxicity, narcotic effect, blood level after awakening, elimination from the blood and biotransformation of hexobarbital in rats of different ages after induction with barbital and carbon tetrachloride poisoning].
    Klinger W
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):5-18. PubMed ID: 5448769
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyproterone acetate pretreatment on the in vitro metabolism of aniline, hexobarbital and 3 H-digitoxigenin.
    Talcott RE; Stohs SJ
    J Pharmacol Exp Ther; 1973 Feb; 184(2):419-23. PubMed ID: 4688178
    [No Abstract]   [Full Text] [Related]  

  • 13. Disulfiram impairment of drug metabolism by rat liver microsomes.
    Stripp B; Greene FE; Gillette JR
    J Pharmacol Exp Ther; 1969 Dec; 170(2):347-54. PubMed ID: 4391007
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic differences in the microsomal metabolism of the isomers of hexobarbital.
    McCarthy JS; Stitzel RE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):772-8. PubMed ID: 5111462
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of hexobarbital metabolism by pyridyl derivatives.
    Varga F; Hankovszky OH; Hideg K; Fischer E; Szily T
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):235-45. PubMed ID: 4807136
    [No Abstract]   [Full Text] [Related]  

  • 16. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 17. Diphenylhydantoin effects on hexobarbital and aniline biotransformation in male rats: differences between in vitro and in vivo observations.
    Gut I; Becker BA
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):253-8. PubMed ID: 1209623
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
    Cherala G; Shapiro BH; D'mello AP
    Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thiamine and dietary linoleate levels on hepatic drug metabolism in the male rat.
    Wade AE; Caster WO; Greene FE; Meadows JS
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):466-73. PubMed ID: 5403612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.